» Articles » PMID: 2117660

Interferon-gamma Induced Exacerbation of Systemic Lupus Erythematosus

Overview
Journal J Rheumatol
Specialty Rheumatology
Date 1990 Jun 1
PMID 2117660
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

A patient with presumed rheumatoid arthritis based on clinical and serological evidence was subjected by her physician to interferon-gamma (IFN-gamma) therapy and developed a life threatening multiorgan flare of systemic lupus erythematosus (SLE). Pulse cyclophosphamide therapy in conjunction with plasmapheresis led to complete remission. Retrospective analysis of serum drawn before IFN-gamma was started revealed high DNA binding capacity. Thus, similar to observations in lupus-prone animals, IFN-gamma may have induced an exacerbation of preexisting SLE.

Citing Articles

Th2 to Th1 Transition Is Required for Induction of Skin Lesions in an Inducible and Recurrent Murine Model of Cutaneous Lupus-Like Inflammation.

Haddadi N, Mande P, Brodeur T, Hao K, Ryan G, Moses S Front Immunol. 2022; 13:883375.

PMID: 35833127 PMC: 9271959. DOI: 10.3389/fimmu.2022.883375.


Effectiveness and safety of allergen immunotherapy in patients with allergic rhinitis complicated by rheumatic autoimmune diseases: a case series study.

Fujioka K, Kasahara A, Kida T, Fujii W, Seno T, Wada M Allergy Asthma Clin Immunol. 2022; 18(1):63.

PMID: 35818067 PMC: 9275025. DOI: 10.1186/s13223-022-00703-0.


Cytokines as Biomarkers in Systemic Lupus Erythematosus: Value for Diagnosis and Drug Therapy.

Idborg H, Oke V Int J Mol Sci. 2021; 22(21).

PMID: 34768756 PMC: 8582965. DOI: 10.3390/ijms222111327.


Bite of the wolf: innate immune responses propagate autoimmunity in lupus.

Gupta S, Kaplan M J Clin Invest. 2021; 131(3).

PMID: 33529160 PMC: 7843222. DOI: 10.1172/JCI144918.


High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus.

Oke V, Gunnarsson I, Dorschner J, Eketjall S, Zickert A, Niewold T Arthritis Res Ther. 2019; 21(1):107.

PMID: 31036046 PMC: 6489203. DOI: 10.1186/s13075-019-1878-y.